Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Semaglutide for Polycystic Kidney Disease
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial will investigate if a two-year treatment with a medication used for weight management can slow down kidney growth in adults with a specific kidney disease who are overweight or obese. The study will also look at
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service